Article March 4, 2009

Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

Henry A. Nasrallah, MD; Matcheri S. Keshavan, MD; Francine M. Benes David, MD; L. Braff Alan I. Green, MD; Rachel E. Gur; John M. Kane, MD; Diana O. Perkins, MD, MPH; Peter J. Weiden, MD; Daniel R. Weinberger, MD; Christoph U. Correll, MD

J Clin Psychiatry 2009;70(suppl 1):4-46

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

In mid-February 2008, a panel of 10 nationally recognized schizophrenia research experts wasassembled in a Schizophrenia Summit to focus on controversies that exist in treating patients withschizophrenia. The current literature related to the diagnosis and etiopathology of schizophrenia wasevaluated regarding the identification of a prodromal phase, brain changes, cognitive impairments,genetic factors, and use of neuroimaging in patients with schizophrenia.’ ‹